Get Your Free Guide to Understanding Xtandi Cost Options

Understanding Xtandi and Its Costs

Xtandi (enzalutamide) is a prescription medication used to treat certain types of prostate cancer. It works by blocking androgens, which are male hormones that can fuel prostate cancer growth. The drug is prescribed for men with castration-resistant prostate cancer, which means the cancer continues to progress even when testosterone levels are lowered through other treatments.

Free Guide to Sleep Apnea Treatment Options in Maryland →

The cost of Xtandi varies significantly depending on several factors. The wholesale price for a monthly supply can range from $8,000 to $15,000 or more before any discounts or insurance coverage. However, what patients actually pay out of pocket depends heavily on their insurance plan, whether they have coverage through Medicare or Medicaid, and what programs they may learn about through resources like cost guides.

According to data from pharmaceutical pricing databases, Xtandi ranks among the higher-cost cancer medications on the market. The drug comes in 40-milligram capsules, and typical prescriptions involve taking multiple capsules daily. A patient's monthly costs could be anywhere from a few dollars with comprehensive insurance coverage to thousands of dollars without insurance or with high deductible plans.

Understanding how Xtandi pricing works is the first step toward exploring what options might reduce out-of-pocket expenses. Different patients face different cost situations based on their specific insurance coverage, income level, and access to discount programs. A guide about cost options can help patients and caregivers understand these different pathways.

Practical Takeaway: Before exploring cost-reduction options, gather your prescription details, insurance information, and recent income statements. Having this information ready will help you understand which options may work for your situation.

How Insurance Coverage Affects What You Pay

Insurance plans vary widely in how they cover Xtandi. Some plans classify the drug as a specialty medication, which often means higher out-of-pocket costs. Other plans may require prior authorization, meaning your doctor must get approval from the insurance company before the prescription can be filled. Prior authorization requirements can delay treatment, so understanding your plan's specific rules matters.

Your Guide to Transmission Oil Change Costs →

Most commercial insurance plans that cover Xtandi place it on a higher cost-sharing tier, sometimes called Tier 4 or Tier 5. This means you may pay a percentage of the drug's cost (called coinsurance) rather than a flat copay. For a drug costing $10,000 per month, coinsurance of 20% would mean you pay $2,000 monthly until you meet your deductible and out-of-pocket maximum.

Medicare coverage for Xtandi falls under Part D, the prescription drug benefit. Medicare beneficiaries with Part D coverage typically face a combination of costs: a deductible (which can be up to $545 in 2024), coinsurance during the initial coverage phase, a coverage gap (often called the "donut hole"), and catastrophic coverage costs. The specifics depend on which Part D plan a beneficiary chooses.

Medicaid coverage varies by state. Some states cover Xtandi more readily than others. State Medicaid programs often have their own prior authorization requirements and may negotiate different pricing with manufacturers. Patients on Medicaid should contact their state program directly to learn about coverage specifics.

Insurance plans also have annual out-of-pocket maximums. Once you reach this limit, your insurance typically covers all remaining costs for the year. For someone taking an expensive medication like Xtandi, reaching the out-of-pocket maximum may happen within just a few months, which is an important planning consideration.

Practical Takeaway: Review your specific insurance plan's formulary (list of covered drugs) and cost-sharing tier for Xtandi. Call your insurance provider to ask about prior authorization requirements, deductible status, and estimated out-of-pocket costs for a year of treatment.

Manufacturer Assistance Programs and Patient Support

Astellas Pharma, which manufactures Xtandi, offers programs designed to help patients manage medication costs. These programs, often called patient assistance programs or co-pay assistance programs, can reduce what patients pay each month. While these programs have specific requirements, they exist specifically to support patients who face high medication costs.

Learn How Virtual Credit Cards Work and When to Use Them →

Co-pay assistance programs typically work by paying part or all of a patient's monthly co-pay or coinsurance. For example, if your insurance plan requires you to pay $500 monthly for Xtandi, a manufacturer program might cover $400 of that, leaving you responsible for $100. The amount of assistance depends on the specific program and your individual circumstances.

To learn about these programs, patients can contact the manufacturer's patient support line, visit the company's official website, or speak with their oncology care team. Many cancer centers have patient navigators or financial counselors who understand manufacturer programs and can help with the process of learning about options.

These programs typically require proof of insurance, income documentation, and a valid prescription. Processing times vary, but many programs provide assistance within one to two weeks of approval. Some programs offer ongoing monthly assistance, while others may have annual limits on the support provided.

It's important to note that manufacturer programs are voluntary company initiatives, not government programs. They vary in their specific terms, so the details of one company's program may differ from another. A guide focusing on cost options should help patients understand what information these programs typically require and how they generally function.

Practical Takeaway: Contact Astellas Pharma's patient support line or ask your doctor's office to obtain information about current assistance programs. Document the program name, any reference numbers provided, and the contact information for future reference.

Exploring Generic and Alternative Options

As of now, Xtandi remains a brand-name medication without a generic equivalent available in the United States. However, this situation may change in future years when patents expire. Patent expiration dates for Xtandi extend through the mid-2020s, meaning brand-name Xtandi will likely remain the only form available for several more years.

How to Pay Your Ulta Credit Card by Phone →

Several other medications treat prostate cancer using similar mechanisms to Xtandi. These include abiraterone acetate (Zytiga), bicalutamide, and other androgen receptor inhibitors. These alternatives may have different costs and insurance coverage patterns. Some patients find that alternative medications have lower out-of-pocket costs through their specific insurance plans.

Treatment choice, however, should always be made by the patient and their oncologist based on medical factors, not cost alone. Different patients respond differently to different medications. Additionally, treatment history matters—a medication your doctor recommends may depend on what treatments you've already received. A cost guide should help patients understand pricing differences without suggesting that cost should override medical judgment.

Some patients explore purchasing medications through programs that offer discounts on brand-name drugs. These discount programs (sometimes called prescription discount cards or programs) can reduce medication costs by 10% to 30%, though savings vary by medication and pharmacy. These programs are separate from insurance and can sometimes be used when insurance coverage is limited or unavailable.

Pharmacy choice can also affect costs. Some pharmacies negotiate different prices for the same medication. Patients taking expensive medications sometimes find that mail-order pharmacy options offer lower costs than local pharmacies, particularly for ongoing maintenance medications like Xtandi.

Practical Takeaway: Work with your oncology team to understand whether alternative medications might work for your situation. If your doctor confirms that Xtandi is the appropriate choice, then explore pricing at multiple pharmacies before filling your prescription.

Financial Resources and Patient Advocacy Organizations

Multiple organizations focused on prostate cancer provide information about medication costs and financial resources. These include the Prostate Cancer Foundation, Us TOO International, and the American Cancer Society. These organizations maintain databases of information about patient assistance, financial aid programs, and educational resources.

Your Free Guide to DirecTV Customer Service Phone Numbers →

Many hospitals and treatment centers employ financial counselors or patient advocates whose job is to help patients understand costs and explore options. These professionals work within the healthcare system and often have detailed knowledge about local and national resources. Speaking with a financial counselor at your cancer center is often an important step in cost planning.

Nonprofit organizations that focus on cancer medications sometimes offer grants or financial support to patients facing extreme medication costs. The National Organization for Rare Disorders, CancerCare, and Patient Advocate Foundation are examples of organizations that may provide information about financial support. Eligibility and award amounts vary, but many patients don't realize these resources exist.